Lenvatinib combined with PD-1 inhibitor plus Gemox chemotherapy versus plus HAIC for advanced biliary tract cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lenvatinib combined with PD-1 inhibitor plus Gemox chemotherapy versus plus HAIC for advanced biliary tract cancer

Published:2024-03 Issue: Volume:129 Page:111642
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Zhang Ting,Zhu Chengpei,Zhang Nan,Zhang Longhao,Wang Shanshan,Xun Ziyu,Xu Yiyao,Yang Xiaobo,Lu Xin,Zhao Haitao^ORCID

Publisher

Elsevier BV

Reference39 articles.

1. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians;Moris;CA Cancer J. Clin.,2023

2. Biliary tract cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up;Vogel;Ann. Oncol.,2023

3. Cancer statistics, 2023;Siegel;CA Cancer J. Clin.,2023

4. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma;Bertuccio;J. Hepatol.,2019

5. New horizons for precision medicine in biliary tract cancers;Valle;Cancer Discov.,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2024-05-11

2. PD-1 inhibitors combined with chemotherapy versus chemotherapy alone: efficacy and prognostic analysis in recurrent metastatic nasopharyngeal carcinoma;American Journal of Translational Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP